Kinarus Therapeutics Holding AG
SIX:KNRS

Watchlist Manager
Kinarus Therapeutics Holding AG Logo
Kinarus Therapeutics Holding AG
SIX:KNRS
Watchlist
Price: 15 CHF 416 566.67% Market Closed
Market Cap: 19.5B CHF
Have any thoughts about
Kinarus Therapeutics Holding AG?
Write Note

Intrinsic Value

KNRS doesn't have a meaningful market cap.

There is not enough data to reliably calculate the intrinsic value of KNRS.

The Intrinsic Value is calculated as the average of DCF and Relative values:

KNRS Intrinsic Value
Not Available
Base Case Scenario
How do you feel about KNRS?
Bearish
Neutral
Bullish

Fundamental Analysis

15 CHF
+416 566.67%
+416 566.67%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Kinarus Therapeutics Holding AG
CH
Airlines
Market Cap
19.5B CHF
IPO
Oct 18, 1999
Employees
-
Switzerland
Market Cap
19.5B CHF
Industry
Airlines
IPO
Oct 18, 1999
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Kinarus Therapeutics Holding AG

Provide an overview of the primary business activities
of Kinarus Therapeutics Holding AG.

What unique competitive advantages
does Kinarus Therapeutics Holding AG hold over its rivals?

What risks and challenges
does Kinarus Therapeutics Holding AG face in the near future?

Has there been any significant insider trading activity
in Kinarus Therapeutics Holding AG recently?

Show all valuation multiples
for Kinarus Therapeutics Holding AG.

Provide P/S
for Kinarus Therapeutics Holding AG.

Provide P/E
for Kinarus Therapeutics Holding AG.

Provide P/OCF
for Kinarus Therapeutics Holding AG.

Provide P/FCFE
for Kinarus Therapeutics Holding AG.

Provide P/B
for Kinarus Therapeutics Holding AG.

Provide EV/S
for Kinarus Therapeutics Holding AG.

Provide EV/GP
for Kinarus Therapeutics Holding AG.

Provide EV/EBITDA
for Kinarus Therapeutics Holding AG.

Provide EV/EBIT
for Kinarus Therapeutics Holding AG.

Provide EV/OCF
for Kinarus Therapeutics Holding AG.

Provide EV/FCFF
for Kinarus Therapeutics Holding AG.

Provide EV/IC
for Kinarus Therapeutics Holding AG.

What are the Revenue projections
for Kinarus Therapeutics Holding AG?

How accurate were the past Revenue estimates
for Kinarus Therapeutics Holding AG?

What are the Net Income projections
for Kinarus Therapeutics Holding AG?

How accurate were the past Net Income estimates
for Kinarus Therapeutics Holding AG?

What are the EPS projections
for Kinarus Therapeutics Holding AG?

How accurate were the past EPS estimates
for Kinarus Therapeutics Holding AG?

What are the EBIT projections
for Kinarus Therapeutics Holding AG?

How accurate were the past EBIT estimates
for Kinarus Therapeutics Holding AG?

Compare the revenue forecasts
for Kinarus Therapeutics Holding AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Kinarus Therapeutics Holding AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Kinarus Therapeutics Holding AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Kinarus Therapeutics Holding AG compared to its peers.

Compare the P/E ratios
of Kinarus Therapeutics Holding AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Kinarus Therapeutics Holding AG with its peers.

Analyze the financial leverage
of Kinarus Therapeutics Holding AG compared to its main competitors.

Show all profitability ratios
for Kinarus Therapeutics Holding AG.

Provide ROE
for Kinarus Therapeutics Holding AG.

Provide ROA
for Kinarus Therapeutics Holding AG.

Provide ROIC
for Kinarus Therapeutics Holding AG.

Provide ROCE
for Kinarus Therapeutics Holding AG.

Provide Gross Margin
for Kinarus Therapeutics Holding AG.

Provide Operating Margin
for Kinarus Therapeutics Holding AG.

Provide Net Margin
for Kinarus Therapeutics Holding AG.

Provide FCF Margin
for Kinarus Therapeutics Holding AG.

Show all solvency ratios
for Kinarus Therapeutics Holding AG.

Provide D/E Ratio
for Kinarus Therapeutics Holding AG.

Provide D/A Ratio
for Kinarus Therapeutics Holding AG.

Provide Interest Coverage Ratio
for Kinarus Therapeutics Holding AG.

Provide Altman Z-Score Ratio
for Kinarus Therapeutics Holding AG.

Provide Quick Ratio
for Kinarus Therapeutics Holding AG.

Provide Current Ratio
for Kinarus Therapeutics Holding AG.

Provide Cash Ratio
for Kinarus Therapeutics Holding AG.

What is the historical Revenue growth
over the last 5 years for Kinarus Therapeutics Holding AG?

What is the historical Net Income growth
over the last 5 years for Kinarus Therapeutics Holding AG?

What is the current Free Cash Flow
of Kinarus Therapeutics Holding AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Kinarus Therapeutics Holding AG.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Kinarus Therapeutics Holding AG

Balance Sheet Decomposition
Kinarus Therapeutics Holding AG

Current Assets 111k
Receivables 108k
Other Current Assets 3k
Current Liabilities 275k
Accounts Payable 56k
Accrued Liabilities 86k
Other Current Liabilities 133k
Non-Current Liabilities -1k
Other Non-Current Liabilities -1k
Efficiency

Earnings Waterfall
Kinarus Therapeutics Holding AG

Revenue
0 CHF
Operating Expenses
-13.9m CHF
Operating Income
-13.9m CHF
Other Expenses
-6k CHF
Net Income
-13.9m CHF

Free Cash Flow Analysis
Kinarus Therapeutics Holding AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

KNRS Profitability Score
Profitability Due Diligence

Kinarus Therapeutics Holding AG's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Negative Free Cash Flow
Negative Net Income
Negative Operating Income
36/100
Profitability
Score

Kinarus Therapeutics Holding AG's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

KNRS Solvency Score
Solvency Due Diligence

Kinarus Therapeutics Holding AG's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
57/100
Solvency
Score

Kinarus Therapeutics Holding AG's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KNRS Price Targets Summary
Kinarus Therapeutics Holding AG

There are no price targets for KNRS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for KNRS?

Click here to dive deeper.

Dividends

Kinarus Therapeutics Holding AG
does not pay dividends
Shareholder Yield

Current shareholder yield for KNRS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

KNRS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More